Evaluation of Sequencing of Anthracyclines and Taxanes for Locally Advanced HER2-negative Breast Cancer
Status:
Recruiting
Trial end date:
2028-09-23
Target enrollment:
Participant gender:
Summary
Phase III randomized clinical trial evaluating the sequencing of anthracyclines and taxanes
in neoadjuvant therapy for locally advanced HER2-negative breast cancer.